TheTradersBias

Risk Appetite Is Definately Back On

NYSE:NVO   Novo Nordisk A/S
Missed the stock. Saw a lot of hype about the drug the last couple of years. Would have loved to have long dated options on it. Will be interesting to see what it does.
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。